In vitro treatment of NK cells with the MMP inhibitor, GM6001, rescues FcγRIIIA loss stimulated by K562 tumor cells, but does not interfere with NK cell degranulation (118), which indicates that FcγRIIIA shedding and degranulation of NK cells are dependent upon separate pathways. The gene discussed is FCGR3A; the disease is neoplasm.